 Duc Ha
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Survivors | 8 | 2025 | 289 | 4.150 |
Why?
| | Lung Neoplasms | 17 | 2023 | 2527 | 3.750 |
Why?
| | Quality of Life | 9 | 2025 | 2954 | 1.270 |
Why?
| | Heart Rate | 3 | 2019 | 802 | 1.170 |
Why?
| | Dyspnea | 3 | 2023 | 255 | 0.890 |
Why?
| | Exercise Test | 5 | 2020 | 622 | 0.870 |
Why?
| | Telerehabilitation | 1 | 2023 | 38 | 0.780 |
Why?
| | Exercise | 5 | 2021 | 2072 | 0.750 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2025 | 189 | 0.750 |
Why?
| | Leisure Activities | 1 | 2021 | 30 | 0.680 |
Why?
| | Exercise Tolerance | 2 | 2020 | 278 | 0.680 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 1111 | 0.620 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 608 | 0.520 |
Why?
| | Chemoradiotherapy | 1 | 2018 | 230 | 0.510 |
Why?
| | Pneumonectomy | 2 | 2016 | 156 | 0.500 |
Why?
| | Lung | 4 | 2023 | 4106 | 0.490 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1045 | 0.480 |
Why?
| | Exercise Therapy | 1 | 2020 | 439 | 0.470 |
Why?
| | Telemedicine | 1 | 2023 | 873 | 0.430 |
Why?
| | Respiratory Tract Diseases | 1 | 2015 | 181 | 0.420 |
Why?
| | Neoplasms, Second Primary | 1 | 2015 | 109 | 0.410 |
Why?
| | Electromagnetic Phenomena | 1 | 2013 | 24 | 0.390 |
Why?
| | Forecasting | 1 | 2015 | 382 | 0.390 |
Why?
| | Cross-Sectional Studies | 5 | 2021 | 5520 | 0.360 |
Why?
| | Bronchoscopy | 1 | 2013 | 225 | 0.360 |
Why?
| | Aged | 10 | 2021 | 24024 | 0.360 |
Why?
| | Heart Diseases | 1 | 2014 | 335 | 0.350 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2013 | 115 | 0.350 |
Why?
| | Neoplasms | 2 | 2025 | 2681 | 0.340 |
Why?
| | Neoplasm Staging | 3 | 2021 | 1372 | 0.340 |
Why?
| | Veterans | 2 | 2020 | 1486 | 0.340 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 5803 | 0.340 |
Why?
| | Humans | 22 | 2025 | 138651 | 0.300 |
Why?
| | Lung Diseases | 1 | 2014 | 785 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 638 | 0.270 |
Why?
| | Adenocarcinoma | 1 | 2013 | 885 | 0.240 |
Why?
| | Patient Reported Outcome Measures | 2 | 2020 | 416 | 0.230 |
Why?
| | Male | 11 | 2021 | 68260 | 0.220 |
Why?
| | Middle Aged | 7 | 2021 | 33604 | 0.210 |
Why?
| | Female | 11 | 2021 | 73763 | 0.210 |
Why?
| | Survivors | 2 | 2023 | 498 | 0.190 |
Why?
| | Logistic Models | 2 | 2021 | 2065 | 0.190 |
Why?
| | Prognosis | 3 | 2016 | 3984 | 0.190 |
Why?
| | Oxygen Consumption | 2 | 2016 | 710 | 0.190 |
Why?
| | Muscles | 1 | 2023 | 332 | 0.190 |
Why?
| | Retrospective Studies | 5 | 2021 | 15909 | 0.180 |
Why?
| | Fatigue | 2 | 2023 | 336 | 0.180 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 53 | 0.170 |
Why?
| | Confidence Intervals | 1 | 2021 | 328 | 0.160 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 110 | 0.160 |
Why?
| | Markov Chains | 1 | 2020 | 126 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2023 | 301 | 0.150 |
Why?
| | Autonomic Nervous System | 1 | 2019 | 78 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1518 | 0.150 |
Why?
| | Walking | 1 | 2023 | 535 | 0.150 |
Why?
| | California | 1 | 2020 | 436 | 0.140 |
Why?
| | Geriatric Assessment | 1 | 2020 | 219 | 0.140 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 561 | 0.140 |
Why?
| | Physical Fitness | 1 | 2019 | 206 | 0.140 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1229 | 0.140 |
Why?
| | Pilot Projects | 1 | 2023 | 1765 | 0.140 |
Why?
| | Psychometrics | 1 | 2022 | 727 | 0.140 |
Why?
| | Survivorship | 1 | 2018 | 50 | 0.130 |
Why?
| | Life Style | 1 | 2020 | 478 | 0.130 |
Why?
| | Time Factors | 2 | 2021 | 6851 | 0.130 |
Why?
| | Disease-Free Survival | 1 | 2018 | 704 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2018 | 213 | 0.120 |
Why?
| | Self Report | 1 | 2021 | 839 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1296 | 0.120 |
Why?
| | Physical Education and Training | 1 | 2016 | 73 | 0.120 |
Why?
| | Treatment Outcome | 2 | 2025 | 10923 | 0.120 |
Why?
| | Risk Assessment | 2 | 2016 | 3433 | 0.120 |
Why?
| | Parasympathetic Nervous System | 1 | 2015 | 28 | 0.120 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2015 | 32 | 0.120 |
Why?
| | Perioperative Period | 1 | 2015 | 64 | 0.120 |
Why?
| | Health Status | 1 | 2021 | 819 | 0.120 |
Why?
| | Survival Analysis | 1 | 2018 | 1309 | 0.110 |
Why?
| | Ohio | 1 | 2015 | 139 | 0.110 |
Why?
| | Mental Health | 1 | 2021 | 738 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2015 | 148 | 0.110 |
Why?
| | Risk Factors | 2 | 2021 | 10252 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3307 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 520 | 0.100 |
Why?
| | Translocation, Genetic | 1 | 2013 | 108 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 896 | 0.090 |
Why?
| | Odds Ratio | 1 | 2014 | 1044 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 1 | 2013 | 195 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1482 | 0.090 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 231 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 665 | 0.080 |
Why?
| | Survival Rate | 1 | 2015 | 1935 | 0.080 |
Why?
| | Multigene Family | 2 | 2008 | 201 | 0.080 |
Why?
| | ErbB Receptors | 1 | 2013 | 609 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5697 | 0.080 |
Why?
| | Chronic Disease | 1 | 2015 | 1805 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 2030 | 0.080 |
Why?
| | Codon, Initiator | 1 | 2009 | 11 | 0.080 |
Why?
| | Lung Diseases, Interstitial | 1 | 2015 | 651 | 0.070 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.070 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2008 | 28 | 0.070 |
Why?
| | Prospective Studies | 1 | 2020 | 7554 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 391 | 0.070 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 129 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 429 | 0.060 |
Why?
| | Antigens, Neoplasm | 1 | 2008 | 316 | 0.060 |
Why?
| | Actins | 1 | 2006 | 419 | 0.050 |
Why?
| | Genome, Human | 1 | 2006 | 416 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 663 | 0.050 |
Why?
| | United States | 1 | 2021 | 14938 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2053 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2006 | 506 | 0.050 |
Why?
| | Adult | 2 | 2015 | 38201 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7677 | 0.040 |
Why?
| | Proteins | 1 | 2006 | 1006 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2009 | 395 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2923 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3392 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2009 | 31 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 144 | 0.020 |
Why?
| | Testis | 1 | 2008 | 157 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 533 | 0.020 |
Why?
| | Azacitidine | 1 | 2008 | 139 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 502 | 0.020 |
Why?
| | Haplorhini | 1 | 2006 | 53 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2006 | 65 | 0.020 |
Why?
| | Retroelements | 1 | 2006 | 48 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 350 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2006 | 330 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2006 | 360 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2155 | 0.010 |
Why?
| | Fetus | 1 | 2008 | 799 | 0.010 |
Why?
| | DNA Methylation | 1 | 2008 | 629 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2174 | 0.010 |
Why?
| | Gene Expression | 1 | 2008 | 1488 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1470 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 998 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2815 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4181 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1992 | 0.010 |
Why?
| | Brain | 1 | 2008 | 2792 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2006 | 2212 | 0.010 |
Why?
| | Animals | 1 | 2006 | 37217 | 0.000 |
Why?
|
|
Ha's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|